MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
Saved in:
| Title: | MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG). |
|---|---|
| Authors: | Siu HWD; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia. monarcc@ctc.usyd.edu.au.; Camperdown, Australia. monarcc@ctc.usyd.edu.au., Tebbutt N; Austin Hospital, Melbourne, Australia., Chantrill L; Shoalhaven Cancer Care Centre, Nowra, Australia., Karapetis C; Flinders Medical Centre, Adelaide, Australia., Steer C; Border Medical Oncology Research Unit, Albury-Wodonga, Australia., Wilson K; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Bailey L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Yip S; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Cuff J; Australasian Gastrointestinal Group (AGITG), Sydney, Australia., Pavlakis N; Northern Cancer Institute, Sydney, Australia., Thavaneswaran S; St Vincent's Public Hospital, Sydney, Australia., Briscoe K; Coffs Harbour Health Campus, Coffs Harbour, Australia., Srivastav R; The Tweed Hospital, Tweed Heads, Australia., Shannon J; Nepean Hospital, Sydney, Australia., Segelov E; Monash Medical Centre, Melbourne, Australia., Tie J; Sunshine Hospital, Melbourne, Australia., Caird S; Gold Coast University Hospital, Gold Coast, Australia., Francesconi A; Sunshine Coast University Hospital, Sunshine Coast, Australia., Price T; The Queen Elizabeth Hospital, Adelaide, Australia., Wuttke M; Royal Hobart Hospital, Hobart, Australia., Ladwa R; Princess Alexandra Hospital, Brisbane, Australia., Sjoquist K; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Burge M; Royal Brisbane and Women's Hospital, Brisbane, Australia.; The Prince Charles Hospital, Brisbane, Australia. |
| Source: | BMC cancer [BMC Cancer] 2021 Aug 18; Vol. 21 (1), pp. 932. Date of Electronic Publication: 2021 Aug 18. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-021-08644-4 |
